HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Josef Jampilek Selected Research
Josef Jampilek Research Topics
Disease
7
Neoplasms (Cancer)
12/2022 - 07/2016
6
Paratuberculosis (Johne's Disease)
01/2018 - 01/2012
3
Tuberculosis (Tuberculoses)
09/2020 - 01/2012
2
Infections
04/2024 - 09/2015
2
Inflammation (Inflammations)
02/2024 - 11/2021
2
Melanoma (Melanoma, Malignant)
10/2020 - 10/2019
1
Acne Vulgaris
04/2024
1
Bacterial Infections (Bacterial Infection)
04/2024
1
Nervous System Diseases (Neurological Disorders)
02/2024
1
Cardiovascular Diseases (Cardiovascular Disease)
02/2024
1
Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
01/2020
1
Sphingolipidoses (Sphingolipidosis)
01/2020
1
Type 2 Diabetes Mellitus (MODY)
01/2019
1
Pain (Aches)
05/2018
1
Toothache (Toothaches)
05/2018
1
Decompression Sickness (Bends)
12/2016
Drug/Important Bio-Agent (IBA)
5
Rifampin (Rifampicin)
FDA Link
Generic
09/2020 - 07/2014
4
Lipids
IBA
02/2024 - 12/2016
2
Lipid Nanoparticles
IBA
12/2022 - 12/2022
2
Liposomes (Liposome)
IBA
12/2022 - 12/2022
2
Vemurafenib
IBA
10/2020 - 10/2019
2
dabrafenib
IBA
10/2020 - 10/2019
2
sphingosine kinase
IBA
01/2020 - 10/2017
2
Sphingolipids
IBA
01/2020 - 10/2017
2
Enzymes
IBA
01/2020 - 10/2017
2
Isoniazid (Ftivazide)
FDA Link
Generic
05/2015 - 01/2012
1
Biocompatible Materials (Biomaterials)
IBA
04/2024
1
Anti-Bacterial Agents (Antibiotics)
IBA
04/2024
1
Clindamycin (Cleocin)
FDA Link
Generic
04/2024
1
Polymers
IBA
12/2022
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
12/2022
1
Volatile Oils (Essential Oils)
IBA
12/2022
1
Antineoplastic Agents (Antineoplastics)
IBA
12/2022
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
11/2021
1
Carbon
IBA
02/2021
1
Phosphotransferases (Kinase)
IBA
10/2020
1
encorafenib
IBA
10/2020
1
Cholesterol
IBA
01/2020
1
Protein Kinases (Protein Kinase)
IBA
10/2019
1
Proteins (Proteins, Gene)
FDA Link
10/2019
1
Glyburide (Glibenclamide)
FDA Link
Generic
01/2019
1
Antitubercular Agents
IBA
01/2018
1
sphingosine 1-phosphate (sphingosine-1-phosphate)
IBA
10/2017
1
Methotrexate (Mexate)
FDA Link
Generic
12/2016
1
Cytarabine (Cytosar-U)
FDA Link
Generic
12/2016
1
3- hydroxy- N- (3- nitrophenyl)naphthalene- 2- carboxamide
IBA
07/2016
1
Vancomycin
FDA Link
Generic
09/2015
1
Ciprofloxacin (Cipro)
FDA Link
Generic
07/2014
1
Pyrazinamide
FDA Link
Generic
01/2012
Therapy/Procedure
5
Therapeutics
04/2024 - 12/2016
1
Drug Therapy (Chemotherapy)
12/2022
1
Traditional Medicine (Folk Remedies)
05/2018